Prevalence and patterns of tobacco and/or nicotine product use in Japan (2017) after the launch of a heated tobacco product ( IQOS®): a cross-sectional study
- PMID: 35528952
- PMCID: PMC9069173
- DOI: 10.12688/f1000research.52407.2
Prevalence and patterns of tobacco and/or nicotine product use in Japan (2017) after the launch of a heated tobacco product ( IQOS®): a cross-sectional study
Abstract
Background: Several smoke-free tobacco and/or nicotine-containing products (TNP) have emerged in recent years to support tobacco harm reduction strategies and reduce individual health risks and population harm relative to continued cigarette smoking. This paper describes the nationwide prevalence and patterns of TNP use in Japan following the commercialization of one such smoke-free TNP, the heated tobacco product IQOS® (Philip Morris International). Methods: We analyzed the first annual data (2016-2017) of two repeated cross-sectional surveys conducted in a representative sample of the Japanese general adult (≥20 years of age) population (N = 4,878) and a sample of adult IQOS users (N = 2,000). We assessed the prevalence of current TNP use according to type of product (cigarettes, IQOS, e-cigarettes, and other TNPs) in the general population and patterns of TNP use in the IQOS user sample. Results: The prevalence of current use across all TNP in the sampled general population was 18.5% (95% confidence interval 17.2-19.5%), with 17.5% (16.4-18.6%) for cigarette smoking and 1.8% (1.4-2.2%) for IQOS use. Regarding the distribution of patterns of use in the IQOS user survey, the majority (63.4% [61.2-65.6%]) were exclusive users of IQOS, followed by 20.6% (18.7-22.5%) of individuals who reported dual use of IQOS and cigarettes. Conclusions: In Japan, cigarette smoking remains the most prevalent way of consuming TNP; however, IQOS is being adopted by a growing number of adult Japanese smokers. These findings serve as baseline data for monitoring trends over time in the use and adoption of potential smoke-free TNP in Japan.
Keywords: IQOS; Japan; cross-sectional survey; heat-not-burn; heated tobacco product; smoking.
Copyright: © 2022 Afolalu EF et al.
Conflict of interest statement
Competing interests: All authors are/were employees of Philip Morris International. Philip Morris International is the sole source of funding and sponsor of this research. IQOS is manufactured by Philip Morris Products S.A.
Figures
Similar articles
-
Risk perception of IQOS™ and cigarettes: Temporal and cross-country comparisons.SSM Popul Health. 2022 May 17;18:101123. doi: 10.1016/j.ssmph.2022.101123. eCollection 2022 Jun. SSM Popul Health. 2022. PMID: 35669892 Free PMC article.
-
Household Surveys in the General Population and Web-Based Surveys in IQOS Users Registered at the Philip Morris International IQOS User Database: Protocols on the Use of Tobacco- and Nicotine-Containing Products in Germany, Italy, and the United Kingdom (Greater London), 2018-2020.JMIR Res Protoc. 2019 May 9;8(5):e12061. doi: 10.2196/12061. JMIR Res Protoc. 2019. PMID: 31094340 Free PMC article.
-
Awareness, experience and prevalence of heated tobacco product, IQOS, among young Korean adults.Tob Control. 2018 Nov;27(Suppl 1):s74-s77. doi: 10.1136/tobaccocontrol-2018-054390. Epub 2018 Aug 29. Tob Control. 2018. PMID: 30158210 Free PMC article.
-
Heat-not-burn tobacco products: an emerging threat to cardiovascular health.Am J Physiol Heart Circ Physiol. 2020 Dec 1;319(6):H1234-H1239. doi: 10.1152/ajpheart.00708.2020. Epub 2020 Oct 2. Am J Physiol Heart Circ Physiol. 2020. PMID: 33006919 Free PMC article. Review.
-
IQOS - a heat-not-burn (HnB) tobacco product - chemical composition and possible impact on oxidative stress and inflammatory response. A systematic review.Toxicol Mech Methods. 2020 Feb;30(2):81-87. doi: 10.1080/15376516.2019.1669245. Epub 2019 Oct 2. Toxicol Mech Methods. 2020. PMID: 31532297
Cited by
-
Protocol for the "magnitude of cigarette substitution after initiation of e-cigarettes and its impact on biomarkers of exposure and potential harm in dual users" (MAGNIFICAT) study.Front Public Health. 2024 Mar 21;12:1348389. doi: 10.3389/fpubh.2024.1348389. eCollection 2024. Front Public Health. 2024. PMID: 38584934 Free PMC article.
-
A Scoping Review of Behavioural Studies on Heated Tobacco Products.Cureus. 2024 Jul 30;16(7):e65773. doi: 10.7759/cureus.65773. eCollection 2024 Jul. Cureus. 2024. PMID: 39211653 Free PMC article.
-
Bridging approaches to facilitate innovation: building an approach for heated tobacco products from case studies in the food and drug domains a comparative review.Arch Toxicol. 2025 Aug;99(8):3091-3103. doi: 10.1007/s00204-025-04081-5. Epub 2025 May 21. Arch Toxicol. 2025. PMID: 40399495 Free PMC article. Review.
-
Risk perception of IQOS™ and cigarettes: Temporal and cross-country comparisons.SSM Popul Health. 2022 May 17;18:101123. doi: 10.1016/j.ssmph.2022.101123. eCollection 2022 Jun. SSM Popul Health. 2022. PMID: 35669892 Free PMC article.
-
Understanding Factors Associated with Motivation to Quit Vaping among Vapers in the Federal Territory of Kuala Lumpur, Malaysia.Healthcare (Basel). 2023 Jul 8;11(14):1980. doi: 10.3390/healthcare11141980. Healthcare (Basel). 2023. PMID: 37510421 Free PMC article.
References
-
- Institute of Medicine: Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction . Washington, DC: The National Academies Press;2001. - PubMed
-
- Philip Morris International: Our Tobacco Heating System IQOS. 2020. Reference Source
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical